| I. Current Status and New Development |
|
|
An Overview of Collection, Processing, Storage and Quality Monitoring of Platelets |
|
|
1 | (18) |
|
|
|
|
|
|
|
|
|
|
|
New Perspective in Manufacturing of Platelets from Whole Blood and Apheresis |
|
|
19 | (18) |
|
|
|
|
|
|
|
|
|
|
|
|
|
37 | (20) |
|
|
|
|
|
|
|
|
|
|
|
The Effects of Metabolic Additives on Platelet Storage |
|
|
57 | (18) |
|
|
|
|
|
|
|
|
|
|
|
|
|
75 | (30) |
|
|
|
|
|
|
|
|
|
|
|
|
|
105 | (26) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lyophilized Platelets for Transfusion |
|
|
131 | (38) |
|
|
|
|
|
|
|
|
|
|
|
Preservation of Platelet Function after Cardiac Surgery and Apheresis |
|
|
169 | (30) |
|
|
|
|
|
|
|
|
|
|
| II. Platelet Storage Lesion and Quality Monitoring |
|
|
Biocojpatibility Assessment of Filter Materials |
|
|
199 | (18) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cytoskelal Changes during Platelet Storage |
|
|
217 | (10) |
|
|
|
|
|
|
Biological Response Modifiers in Platelet Transfusion Therapy |
|
|
227 | (36) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Microvesicles in Platelet Concentrates |
|
|
263 | (16) |
|
|
|
|
|
|
|
|
|
|
|
Platelet and Residual Leukocyte Counting in Platelet Components |
|
|
279 | (40) |
|
|
|
|
|
|
|
|
|
|
|
Practical Aspects of Platelet Storage Lesion and Quality |
|
|
319 | (18) |
|
|
|
|
|
|
|
|
|
|
| III. Alternatives to Platelets |
|
|
Thrombopoietin and Ex Vivo Expansion of Megakaryocytes |
|
|
337 | (26) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Alternatives to Platelet Transfusion |
|
|
363 | (20) |
|
|
|
|
|
|
|
|
|
|
| IV. Safety/Efficacy and Immunomodulatory Aspects |
|
|
Alternative Strategies in Platelet Therapy |
|
|
383 | (18) |
|
|
|
|
|
|
Bacterial Contamination of Platelets |
|
|
401 | (14) |
|
|
|
|
|
|
|
|
|
|
|
Ultraviolet and Gamma-Irradiated Platelets: In Vitro and In Vivo Response |
|
|
415 | (24) |
|
|
|
|
|
|
Inactivation of Infectious Pathogens and Leukocytes in Platelet Concentrates |
|
|
439 | (28) |
|
|
|
|
|
|
Trigger Factors for Prophylactic Platelet Transfusions |
|
|
467 | (18) |
|
|
|
|
|
|
Strategies to Provide Effective Platelets to Patients Refractory to Random Donor Platelet Support |
|
|
485 | (18) |
|
|
|
|
|
|
|
|
503 | (28) |
|
|
|
|
|
|
Consensus Conference on Platelet Transfusion: Royal College of Physicians of Edinburgh |
|
|
531 | (6) |
|
|
|
|
|
| Epilogue |
|
537 | |
Shopping Cart
